CCM chief defends demerger exercise


KUALA LUMPUR: Chemical Company of Malaysia Bhd’s (CCM) head honcho has defended the company’s demerger exercise as one that will not result in any losses to shareholders.

Speaking to reporters at a briefing here yesterday, CCM group managing director Leonard Ariff Abdul Shatar acknowledged that it would take time for the market to digest the recently announced corporate exercise to de-gear and demerge from its profit-making pharmaceutical unit CCM Duopharma Biotech Bhd.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , CCM , CCM Duopharma , demerger , stock , shares ,

Next In Business News

Ringgit set for cautious week versus US dollar amid West Asia conflict
Pursuing the Elixir of growth
The AI finance revolution
Energy crunch singes New Delhi street stalls
A winner in medals
Winners and losers in carbon-priced climate
A time of carbon reckoning
Gulf luxury car profits under siege
Oil & war the big woes
‘Mr Brexit’ made winning�calls amid Iran war

Others Also Read